Is CLS a Buy or a Sell? The Bull and Bear Case (2026)

Last updated July 2026

Short answer

Both cases are real, which is why the question is contested. The bull case for Celestica (CLS) rests on Hyperscaler-driven CCS growth: The Connectivity & Cloud Solutions segment is the engine of the story, reaching roughly ~$3.24 billion in Q1 2026 and growing about ~76% year over year. The bear case rests on customer concentration is the headline risk: as of Q1 2026 three customers each represented at least 10% of revenue (roughly 35%, 15%, and 15%), and the top ten customers made up about ~78% of revenue, so losing or being de-prioritized by a single hyperscaler would matter a lot. Analysts covering it publish targets from $360.00 to $550.00 against a $328.35 price, so even the professionals disagree by 42% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.

Celestica is a Toronto-based electronics manufacturing services (EMS) and supply-chain company that designs, builds, and tests hardware for other companies. It reports in two segments. Connectivity & Cloud Solutions (CCS) is the larger and faster-growing one, serving data-center and communications customers with networking switches, servers, storage, and increasingly custom AI/ML compute hardware; in Q1 2026 CCS was about ~80% of total revenue and grew roughly ~76% year over year, with hyperscaler customers making up the majority of that segment. Advanced Technology Solutions (ATS) is the diversified segment covering aerospace and defense, industrial, HealthTech, and capital equipment. The company makes money on the volume and complexity of the hardware it manufactures and on higher-value design and joint-design-manufacturing (JDM) work, where margins are structurally better than commodity contract assembly. Historically Celestica was a lower-margin, lower-multiple contract manufacturer competing on scale and efficiency. The shift toward AI infrastructure changed the story: demand for 800G networking switches and next-generation AI/ML compute programs from a concentrated set of hyperscaler customers drove rapid revenue growth and modest margin expansion, and the stock re-rated sharply as investors began treating it as an AI-infrastructure play rather than a traditional EMS name. Management has repeatedly raised guidance through 2025 and into 2026 on that demand.

The bull case: what would have to be true for $550.00

The most optimistic published target on CLS is $550.00, +67.5% from the $328.35 price as of July 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.

Hyperscaler-driven CCS growth

The Connectivity & Cloud Solutions segment is the engine of the story, reaching roughly ~$3.24 billion in Q1 2026 and growing about ~76% year over year. Management guided to roughly ~70% CCS revenue growth for full-year 2026, driven by data-center demand from a concentrated hyperscaler customer base. This is what shifted Celestica from a traditional contract manufacturer into an AI-infrastructure name in investors' eyes.

AI networking and compute content

Growth is concentrated in specific high-demand products: 800G networking switches ramping across hyperscaler customers, and next-generation AI/ML compute programs. In Q1 2026 the communications end market grew about ~69% and the enterprise end market about ~101%, the latter tied to a planned hyperscaler AI/ML compute ramp. As AI clusters scale, the dollar content of networking and custom compute hardware per build has been rising.

Margin expansion and mix

EMS has historically been a thin-margin business, but Celestica's adjusted operating margin reached about ~8.0% in Q1 2026, up roughly 90 basis points year over year, with full-year 2026 guidance around ~8.1%. The improvement reflects scale and a richer mix toward higher-value design and CCS work rather than commodity assembly. Whether margins hold or expand further is a key part of the valuation debate.

Design and JDM differentiation

Celestica increasingly competes on joint-design-manufacturing (JDM) and engineering, not just assembly, which helped it take a leading slice of the high-speed Ethernet switch market versus EMS rivals. Deeper design involvement tends to carry better margins and stickier customer relationships. This is the lever the company points to for sustaining differentiation if pure-volume competition intensifies.

The bear case: what would have to be true for $360.00

The most pessimistic published target is $360.00, +9.6% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Celestica is worth if the risks below bite instead of the drivers above.

Customer concentration is the headline risk: as of Q1 2026 three customers each represented at least 10% of revenue (roughly 35%, 15%, and 15%), and the top ten customers made up about ~78% of revenue, so losing or being de-prioritized by a single hyperscaler would matter a lot. EMS has historically run thin margins, leaving limited cushion if pricing or volumes compress. The business is tied to AI capital spending, which is cyclical and could slow or pause after a heavy buildout phase. And the stock has re-rated to a much higher multiple than its EMS history, so it carries both competition from Jabil, Flex, Foxconn, and ODMs and the risk that high growth expectations are not met.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding CLS already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.

Where analysts land on CLS

18 analysts cover CLS, with an average target of $448.00 (+36.4% against $328.35) and a split of 20 buy, 1 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the CLS forecast and price target page.

How is CLS valued? (as of June 2026)

Price
$328.35
Market cap
$37.75B
P/E (TTM)
34.10
Forward P/E
18.17
Price / book
15.23
52-week range
$173.23 to $474.03

Snapshot for CLS as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.

  • Q1 2026 revenue: ~$4.05B (up ~53% YoY)
  • CCS segment growth: ~76% YoY in Q1 2026 (~80% of revenue)
  • 2026 revenue guidance: ~$19B (raised from ~$17B)
  • Adjusted operating margin: ~8.0% Q1 2026; ~8.1% 2026 guide
  • P/E ratio: ~40-52x (varies by source/date)
  • Market capitalization: ~$38-39B

These figures are tied to the June 2026 reporting picture and Celestica's Q1 2026 results announced in late April 2026. The company has repeatedly beaten and raised guidance on AI-driven demand, and its valuation multiple has expanded well above its historical EMS range to reflect those growth expectations. A premium multiple means the stock is more sensitive to any disappointment in growth or margins than a traditional contract manufacturer would be.

How do you decide if CLS is a buy?

Rather than asking whether CLS is a buy in the abstract, it tends to help to answer four questions:

  • Thesis: do you believe the bull case above, and is it still true today?
  • Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
  • Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
  • Overlap: check whether you already hold CLS indirectly through an index or sector ETF before adding more.

What would change your mind on CLS

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

  • Bull case breaks if: Hyperscaler-driven CCS growth stalls in the reported numbers rather than in the narrative around them.
  • Bear case breaks if: customer concentration is the headline risk: as of Q1 2026 three customers each represented at least 10% of revenue (roughly 35%, 15%, and 15%), and the top ten customers made up about ~78% of revenue, so losing or being de-prioritized by a single hyperscaler would matter a lot fails to materialise over several reporting periods while the drivers keep compounding.
  • Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the CLS stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about CLS against your real portfolio and see your actual exposure before deciding.

Investing in Celestica with AI

Connect the broker you already use and ask Walnut's AI how CLS fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

FAQ

Is CLS a good stock to buy right now?

+

That depends on which case you find more convincing, and both are on this page. The bull case rests on Hyperscaler-driven CCS growth, with q1 2026 revenue at ~$4.05B (up ~53% YoY). The bear case rests on customer concentration is the headline risk: as of Q1 2026 three customers each represented at least 10% of revenue (roughly 35%, 15%, and 15%), and the top ten customers made up about ~78% of revenue, so losing or being de-prioritized by a single hyperscaler would matter a lot. Analysts covering it are spread from $360.00 to $550.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Should I sell CLS?

+

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Customer concentration is the headline risk: as of Q1 2026 three customers each represented at least 10% of revenue (roughly 35%, 15%, and 15%), and the top ten customers made up about ~78% of revenue, so losing or being de-prioritized by a single hyperscaler would matter a lot. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $360.00, +9.6% from the $328.35 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

What is the bull case for CLS?

+

Hyperscaler-driven CCS growth. The Connectivity & Cloud Solutions segment is the engine of the story, reaching roughly ~$3.24 billion in Q1 2026 and growing about ~76% year over year. The most optimistic analyst target on CLS is $550.00, +67.5% from the $328.35 price. That figure is only reachable if this thesis works close to its best case.

What is the bear case for CLS?

+

Customer concentration is the headline risk: as of Q1 2026 three customers each represented at least 10% of revenue (roughly 35%, 15%, and 15%), and the top ten customers made up about ~78% of revenue, so losing or being de-prioritized by a single hyperscaler would matter a lot. EMS has historically run thin margins, leaving limited cushion if pricing or volumes compress. The business is tied to AI capital spending, which is cyclical and could slow or pause after a heavy buildout phase. And the stock has re-rated to a much higher multiple than its EMS history, so it carries both competition from Jabil, Flex, Foxconn, and ODMs and the risk that high growth expectations are not met. The most pessimistic published target is $360.00, +9.6% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

What does Celestica do?

+

Celestica is a Toronto-based electronics manufacturing services (EMS) and supply-chain company that designs, builds, and tests hardware for other companies.

What would have to change for CLS to stop being worth holding?

+

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Hyperscaler-driven CCS growth) stalling in the reported numbers rather than in the narrative, the risk above (customer concentration is the headline risk: as of Q1 2026 three customers each represented at least 10% of revenue (roughly 35%, 15%, and 15%), and the top ten customers made up about ~78% of revenue, so losing or being de-prioritized by a single hyperscaler would matter a lot) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

Is CLS a good stock to buy right now?

+

That depends on your goals, time horizon, and risk tolerance, and this is not advice. The bull case is rapid CCS growth, AI networking and compute content, and rising margins from hyperscaler demand. The bear case is heavy customer concentration, historically thin EMS margins, exposure to a cyclical AI-capex cycle, and a much higher valuation than its past. Weigh both against your own situation.

What does Celestica do?

+

Celestica is an electronics manufacturing services (EMS) company that designs, builds, and tests hardware for other companies. Its CCS segment makes networking switches, servers, storage, and custom AI/ML compute hardware for data-center and communications customers, while its ATS segment serves aerospace and defense, industrial, HealthTech, and capital-equipment markets. It earns money on manufacturing volume, complexity, and higher-value design work.

Does CLS pay a dividend?

+

No. As of June 2026 Celestica does not pay a dividend to shareholders. Any return from holding the stock would come from changes in the share price rather than dividend income. That is common for companies reinvesting heavily into a fast-growing part of their business, though it means income-focused investors get no cash payout.

Walnut is informational, not investment advice, and gives no verdict on CLS. Analyst targets referenced here come from a July 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.

Related stocks

    Is CLS a Buy or a Sell? The Bull and Bear Case (2026), Walnut